Adriana de Sá Caldas

Adriana de Sá Caldas

Auto-generated profile, based on publicly available information

Adriana de Sá Caldas

Departamento de Endocrinologia e Metabologia, Hospital Universitário, Universidade Federal do Maranhão, São Luís, Maranhão, Brasil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
FRFernando Barros Costa Ribeiro
Fernando Barros Costa Ribeiro
AAANA Ferreira Pereira de DE ALMEIDA
ANA Ferreira Pereira de DE ALMEIDA
ACAdriana de Sá Caldas
Adriana de Sá Caldas
GNGilvan Cortês Nascimento
Gilvan Cortês Nascimento
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
CSCarla Souza Pereira Sobral
Carla Souza Pereira Sobral
Objective: To identify factors potentially associated with radioiodine-refractory disease among patients treated for differentiated thyroid carcinoma at a referral center in Northeastern Brazil. Methods: A total of 554 medical records of patients with differentiated thyroid carcinoma treated between January 2010 and August 2024 were evaluated. Radioiodine-refractory disease tumors were detected in 44 (7.9%) patients. Clinical, laboratory, and radiological data were compared between the radioiodine-refractory disease and non-radioiodine-refractory disease groups to determine factors associated with poor differentiated thyroid carcinoma outcomes. [...] Abstract Objective: To identify factors potentially associated with radioiodine-refractory disease among patients treated for differentiated thyroid carcinoma at a referral center in Northeastern Brazil. Methods: A total of 554 medical records of patients with differentiated thyroid carcinoma treated between January 2010 and August 2024 were evaluated. Radioiodine-refractory disease tumors were detected in 44 (7.9%) patients. Clinical, laboratory, and radiological data were compared between the radioiodine-refractory disease and non-radioiodine-refractory disease groups to determine factors associated with poor differentiated thyroid carcinoma outcomes.